EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Nanomedicine Strategies for Targeting Tumor Stroma

Mei-Chi Su iD, Susheel Kumar Nethi iD, Pavan Kumar Dhanyamraju iD, Swayam Prabha iD

Cancers · 17.08.2023 · 15 (16) · 4145

DOI: 10.3390/cancers15164145 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Cancers, online erschienen am 17.08.2023. Verfasst von Mei-Chi Su und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Experimental and Clinical Pharmacology, College of Pharmacy, University of Minnesota, Minneapolis, MN 55455, USA. Die Arbeit wurde bisher 31-mal zitiert (Crossref) und nennt 286 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Temple University, OVPR (Temple University), Basser Cancer Center and American Cancer Society.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The tumor stroma, or the microenvironment surrounding solid tumors, can significantly impact the effectiveness of cancer therapies. The tumor microenvironment is characterized by high interstitial pressure, a consequence of leaky vasculature, and dense stroma created by excessive deposition of various macromolecules such as collagen, fibronectin, and hyaluronic acid (HA). In addition, non-cancerous cells such as cancer-associated fibroblasts (CAFs) and the extracellular matrix (ECM) itself can promote tumor growth. In recent years, there has been increased interest in combining standard cancer treatments with stromal-targeting strategies or stromal modulators to improve therapeutic outcomes. Furthermore, the use of nanomedicine, which can improve the delivery and retention of drugs in the tumor, has been proposed to target the stroma. This review focuses on how different stromal components contribute to tumor progression and impede chemotherapeutic delivery. Additionally, this review highlights recent advancements in nanomedicine-based stromal modulation and discusses potential future directions for developing more effective stroma-targeted cancer therapies.

Schlagwörter

Stichwörter der Autor:innen

cancer therapycancer-associated fibroblastscollagenextracellular matrixfibronectinhyaluronic acidnanomedicinetumor microenvironment

Autor:innen und Institutionen

  • Department of Experimental and Clinical Pharmacology, College of Pharmacy, University of Minnesota, Minneapolis, MN 55455, USA.
  • Nanovaccine Institute, Department of Chemical & Biological Engineering, Iowa State University, Ames, IA 50011, USA.
  • Fels Cancer Institute of Personalized Medicine, Lewis-Katz School of Medicine, Temple University, Philadelphia, PA 19140, USA.
  • Department of Cancer and Cellular Biology, Lewis Katz School of Medicine, Temple University, Philadelphia, PA 19140, USA.
  • Cancer Signaling and Microenvironment Program, Fox Chase Cancer Center, Temple University, Philadelphia, PA 19111, USA.

ORCID-Profile: Mei-Chi Su, Susheel Kumar Nethi, Pavan Kumar Dhanyamraju, Swayam Prabha

Förderung

  • Temple University
  • OVPR (Temple University), Basser Cancer Center and American Cancer Society

Zitieren

APA

Su, M. C., Nethi, S. K., Dhanyamraju, P. K., & Prabha, S. (2023). Nanomedicine Strategies for Targeting Tumor Stroma. Cancers, 15(16), 4145. https://doi.org/10.3390/cancers15164145

Vancouver

Su MC, Nethi SK, Dhanyamraju PK, Prabha S. Nanomedicine Strategies for Targeting Tumor Stroma. Cancers. 2023;15(16):4145. doi:10.3390/cancers15164145

BibTeX
@article{Su2023,
  author = {Su, Mei-Chi and Nethi, Susheel Kumar and Dhanyamraju, Pavan Kumar and Prabha, Swayam},
  title = {Nanomedicine Strategies for Targeting Tumor Stroma},
  journal = {Cancers},
  year = {2023},
  volume = {15},
  number = {16},
  pages = {4145},
  doi = {10.3390/cancers15164145}
}
Kostenlos starten →